ArticleCureus2026
Granulomatous Mastitis Mimicking Infection: A Case Report of Therapeutic Challenges and Evolving Management.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 24-year-old woman presented with right breast pain and a progressively enlarging mass that had persisted for 4 months. It was initially managed as a breast abscess. However, after multiple courses of antibiotics, incision and drainage, and intralesional corticosteroid injections, her symptoms did not improve, and new areas of involvement developed. Breast ultrasound showed findings suspicious for an inflammatory lesion, and routine cultures remained negative. Breast core biopsy revealed non-caseating granulomatous inflammation, consistent with granulomatous mastitis. In the setting of a progressive course and poor response to prior therapies, systemic immunosuppressive treatment with methotrexate was initiated. At approximately 7 weeks after methotrexate initiation, she reported overall clinical improvement. In this case, the lack of response to antibiotics raised concerns for an underlying inflammatory process, emphasizing the need for early biopsy and reassessment when the clinical course is atypical. It also reflects the clinical difficulty of deciding when to shift from antibiotics to anti-inflammatory or immunosuppressive treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.